AllianceBernstein’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$196M Buy
599,207
+13,988
+2% +$4.99M 0.06% 221
2025
Q4
$192M Sell
585,219
-9,567
-2% -$3.03M 0.06% 228
2025
Q3
$168M Sell
594,786
-444,604
-43% -$129M 0.05% 253
2025
Q2
$290M Sell
1,039,390
-11,170
-1% -$3.16M 0.09% 172
2025
Q1
$327M Sell
1,050,560
-78,562
-7% -$23.2M 0.12% 148
2024
Q4
$294M Sell
1,129,122
-267,234
-19% -$79.3M 0.1% 157
2024
Q3
$450M Sell
1,396,356
-161,454
-10% -$52.8M 0.15% 119
2024
Q2
$487M Sell
1,557,810
-395,420
-20% -$116M 0.17% 101
2024
Q1
$555M Sell
1,953,230
-106,541
-5% -$31.2M 0.2% 98
2023
Q4
$593M Buy
2,059,771
+258,730
+14% +$70.5M 0.23% 89
2023
Q3
$484M Sell
1,801,041
-53,320
-3% -$13.3M 0.21% 98
2023
Q2
$412M Sell
1,854,361
-61,181
-3% -$14.2M 0.17% 119
2023
Q1
$463M Sell
1,915,542
-61,327
-3% -$15.1M 0.2% 109
2022
Q4
$519M Sell
1,976,869
-92,587
-4% -$24.8M 0.23% 96
2022
Q3
$466M Sell
2,069,456
-39,811
-2% -$9.65M 0.23% 99
2022
Q2
$513M Sell
2,109,267
-96,170
-4% -$23.6M 0.23% 88
2022
Q1
$533M Buy
2,205,437
+6,675
+0.3% +$1.53M 0.21% 97
2021
Q4
$495M Buy
2,198,762
+251,597
+13% +$53.1M 0.17% 106
2021
Q3
$414M Buy
1,947,165
+249,959
+15% +$57.5M 0.16% 119
2021
Q2
$414M Sell
1,697,206
-113,277
-6% -$27.9M 0.17% 121
2021
Q1
$450M Sell
1,810,483
-60,675
-3% -$14.5M 0.2% 99
2020
Q4
$430M Sell
1,871,158
-35,721
-2% -$8.24M 0.2% 94
2020
Q3
$485M Buy
1,906,879
+257,069
+16% +$63.7M 0.26% 73
2020
Q2
$389M Buy
1,649,810
+237,383
+17% +$54.2M 0.23% 82
2020
Q1
$286M Buy
1,412,427
+225,088
+19% +$49.2M 0.21% 96
2019
Q4
$286M Sell
1,187,339
-53,585
-4% -$11.8M 0.16% 124
2019
Q3
$240M Buy
1,240,924
+71,682
+6% +$13.8M 0.15% 132
2019
Q2
$215M Buy
1,169,242
+54,632
+5% +$9.78M 0.13% 148
2019
Q1
$212M Buy
1,114,610
+10,376
+0.9% +$1.98M 0.14% 146
2018
Q4
$215M Sell
1,104,234
-23,968
-2% -$4.68M 0.16% 130
2018
Q3
$234M Sell
1,128,202
-21,516
-2% -$4.24M 0.15% 140
2018
Q2
$212M Sell
1,149,718
-16,359
-1% -$2.89M 0.15% 144
2018
Q1
$199M Sell
1,166,077
-347,307
-23% -$63.8M 0.14% 146
2017
Q4
$263M Buy
1,513,384
+50,568
+3% +$8.95M 0.19% 118
2017
Q3
$273M Buy
1,462,816
+93,213
+7% +$16.5M 0.2% 113
2017
Q2
$236M Buy
1,369,603
+30,181
+2% +$4.91M 0.18% 125
2017
Q1
$220M Buy
1,339,422
+16,880
+1% +$2.8M 0.18% 121
2016
Q4
$193M Sell
1,322,542
-55,752
-4% -$8.39M 0.16% 132
2016
Q3
$230M Buy
1,378,294
+42,408
+3% +$7.17M 0.19% 115
2016
Q2
$203M Sell
1,335,886
-4,012
-0.3% -$624K 0.18% 133
2016
Q1
$201M Sell
1,339,898
-182,019
-12% -$27M 0.17% 135
2015
Q4
$247M Buy
1,521,917
+41,951
+3% +$6.59M 0.21% 110
2015
Q3
$205M Buy
1,479,966
+104,186
+8% +$16.4M 0.18% 125
2015
Q2
$211M Sell
1,375,780
-183
-0% -$29.3K 0.17% 134
2015
Q1
$220M Sell
1,375,963
-12,537
-0.9% -$1.97M 0.18% 130
2014
Q4
$221M Sell
1,388,500
-17,184
-1% -$2.68M 0.18% 126
2014
Q3
$197M Buy
1,405,684
+16,819
+1% +$2.2M 0.17% 138
2014
Q2
$164M Sell
1,388,865
-265,830
-16% -$30.8M 0.14% 164
2014
Q1
$204M Sell
1,654,695
-166,119
-9% -$20.1M 0.18% 131
2013
Q4
$208M Sell
1,820,814
-93,167
-5% -$10.6M 0.19% 124
2013
Q3
$214M Sell
1,913,981
-275,829
-13% -$29.9M 0.21% 113
2013
Q2
$216M Buy
+2,189,810
New +$227M 0.23% 104

Other funds holding AMGN

AllianceBernstein's AMGN Position: Q1 2026 in Review

AllianceBernstein increased its Amgen (AMGN) stake by 2.4% in Q1 2026, buying an estimated $4.99M and bringing the position to 599,207 shares worth $196M. The position accounts for 0.06% of the portfolio, ranked #221.

AllianceBernstein first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $593M in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AllianceBernstein held 599,207 shares of Amgen worth $196M as of Q1 2026.
  • AllianceBernstein bought 13,988 Amgen shares in Q1 2026, an estimated $4.99M.
  • Amgen made up 0.06% of AllianceBernstein's portfolio in Q1 2026, its #221 holding.
  • AllianceBernstein first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Amgen position peaked at $593M in Q4 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.